LivaNova PLC (LIVN)

Market Cap	2.72B
Revenue (ttm)	1.24B
Net Income (ttm)	23.68M
Shares Out	54.30M
EPS (ttm)	0.43
PE Ratio	116.86
Forward PE	14.33
Dividend	n/a
Ex-Dividend Date	n/a

Volume	379,091
Open	51.28
Previous Close	51.36
Day's Range	49.98 - 51.75
52-Week Range	42.75 - 64.48
Beta	1.01
Analysts	Buy
Price Target	67.14 (+34.15%)
Earnings Date	Oct 30, 2024

About LIVN

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable p...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Feb 10, 1993
• Employees: 2,900
• Stock Exchange: NASDAQ
• Ticker Symbol: LIVN
• Website: https://www.livanova.com

Analyst Forecast

According to 7 analysts, the average rating for LIVN stock is "Buy." The 12-month stock price forecast is $67.14, which is an increase of 34.15% from the latest price.

Price Target

$67.14

(34.15% upside)

Analyst Consensus: Buy